April 10 - European earnings season cranks up again, with numbers due from Roche, but European equity gains are starting to make emerging markets look cheap again, says Somerset Capital CEO Dominic Johnson.
European -- seasoned stars to crank up again but will the numbers be big enough to keep equities on a roll this is on look ahead to Thursday's market moving stories. -- one of the first big names to give us Q1 numbers to drugs -- seen enjoying a jump in sales of nearly 4%. That would take revenue to just shy of twelve billion Swiss francs -- getting a fresh -- today. Off to researchers said its experimental anticancer drug was looking promising. European big business still looking very vulnerable to the region's economic crisis that with -- and today. Warning it might have to -- sales targets European stocks stood me up as we go into earning season. But test -- capital CEO Dominic Johnson says this is gains are starting to make developed markets are pricing. The question in our mind is is is -- is is now it's time to buy emerging markets again many simple market in the rear view mirror. And have we seen the end all of the outflow shifts from American markets back into developed markets in particular the State's -- obvious that. The much Marcus clutch equipment. I didn't see any reason to continues that. Discount German CPI number scrutinize tomorrow if any fresh signs of trouble in Europe's growth engine price rises expects to come in. At the same level as the months and Malia meanwhile French inflation expects to more than doubled its speed from February despite signs of stagnation that. -- -- -- now sacked for an Italian debt to auction -- medium to long term debt -- on the sale. Analysts looking to see your friend can continue to enjoy it falling yields despite the absence of government. That's not look ahead to Thursday's market. Stories I'm axle problems as opposed.